Hyperbaric Oxygen Protocols for Long COVID & Chronic Fatigue

New research reveals how pressurized oxygen treatments may rewire damaged cells and restore energy in patients battling persistent post-COVID exhaustion.

Top Hyperbaric Chambers Picks

Premium quality with white-glove delivery included, pre-delivery inspection, and expert support.

Top Pick

Summit to Sea 33″ Dive Hyperbaric Oxygen Chamber

$9,995

• ✅ White-Glove Delivery Included
• ✅ Portable Design
• ✅ Hyperbaric Pressure Chamber
• ✅ Ongoing Expert Phone Support

View Summit to Sea

Premium Choice

Summit to Sea 40″ Dive Vertical Hyperbaric Chamber

$13,995

• ✅ White-Glove Delivery Included
• ✅ Hyperbaric Pressure Chamber
• ✅ Free Shipping Included
• ✅ Ongoing Expert Phone Support

View Summit to Sea

Great Starting Point

Summit to Sea 26″ Shallow Dive Hyperbaric Chamber

$7,995

• ✅ White-Glove Delivery Included
• ✅ Hyperbaric Pressure Chamber
• ✅ Free Shipping Included
• ✅ Ongoing Expert Phone Support

View Summit to Sea

Commercial Grade

OxyRevo Quest36 1.5 to 2.0 ATA Hard Hyperbaric Chamber

$27,999

• ✅ White-Glove Delivery Included
• ✅ Stainless Steel Construction
• ✅ Active Cooling System
• ✅ Ongoing Expert Phone Support

View OxyRevo Quest36 1.5

What Is Hyperbaric Oxygen Therapy?

Hyperbaric oxygen therapy (HBOT) is a medical and wellness intervention in which a person breathes concentrated oxygen inside a pressurized chamber. The increased atmospheric pressure — typically ranging from 1.3 to 3.0 atmospheres absolute (ATA) — allows oxygen to dissolve directly into the blood plasma, rather than being carried solely by red blood cells. This dramatically increases the amount of oxygen delivered to tissues throughout the body, including the brain, muscles, and immune cells.

The concept has been used in conventional medicine for decades, most famously to treat decompression sickness in divers and carbon monoxide poisoning. However, researchers and clinicians have more recently been investigating its potential to address complex, chronic conditions where tissue oxygen levels are chronically depleted or where inflammation and cellular dysfunction are central to the disease process.

For people living with Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), both of those conditions are very much present. That intersection is what has driven a surge in scientific interest — and in patient demand — for structured HBOT protocols targeting these debilitating syndromes.

Long COVID and Chronic Fatigue: The Biological Overlap

To understand why hyperbaric oxygen therapy is being studied for Long COVID and chronic fatigue, it helps to understand what these conditions actually do to the body. Long COVID — the persistence of symptoms for 12 or more weeks after an initial SARS-CoV-2 infection — affects an estimated 10 to 30 percent of people who contract the virus. ME/CFS, which predates COVID-19 but shares striking similarities, is estimated to affect up to 2.5 million Americans.

Both conditions involve overlapping biological disruptions. These include mitochondrial dysfunction (impaired cellular energy production), chronic low-grade neuroinflammation , reduced cerebral blood flow, autonomic nervous system dysregulation, and persistent immune activation. Fatigue in these patients is not ordinary tiredness — it is a profound, post-exertional collapse that worsens with physical or cognitive effort and does not resolve with rest.

Researchers have used brain imaging technologies like SPECT and functional MRI to document reduced blood flow and metabolic activity in the brains of both Long COVID and ME/CFS patients. This hypoperfusion is believed to contribute directly to brain fog, memory difficulties, and emotional dysregulation. HBOT's ability to increase oxygen delivery to these regions makes it a mechanistically logical candidate for intervention.

The Research: What Studies Actually Show

The strongest clinical evidence to date comes from a randomized, double-blind, sham-controlled trial published in 2022 in the journal Nature by researchers at Tel Aviv University and the Sagol Center for Hyperbaric Medicine. In this study, 73 Long COVID patients were assigned to either 40 sessions of HBOT (at 2.0 ATA with 100% oxygen, five days per week for eight weeks) or a placebo protocol using slightly pressurized air. The results were striking.

Patients who received real HBOT showed significant improvements in cognitive function, energy levels, sleep quality, and psychiatric symptoms compared to the sham group. Brain imaging revealed measurable increases in cerebral blood flow and neural activity in multiple regions. Importantly, these were not simply subjective reports — the cognitive improvements were confirmed with standardized neuropsychological testing.

A follow-up analysis from the same research group published in 2023 specifically examined the microstructural changes in the brain, finding that HBOT was associated with repair of white matter integrity — a type of neural tissue damage that is increasingly recognized as a hallmark of Long COVID pathology. This kind of structural brain change is not typically associated with placebo responses, lending significant weight to the findings.

Earlier research on ME/CFS is more limited but points in a similar direction. A 2013 study published in PLOS ONE demonstrated that HBOT reduced symptoms and improved functional capacity in ME/CFS patients, with improvements correlated to changes in brain blood flow measured by SPECT imaging. While larger trials are needed, the mechanistic plausibility and early positive signals are consistent across research groups.

How HBOT Protocols Work: Pressure, Oxygen, and Timing

Not all hyperbaric oxygen therapy is the same. The therapeutic outcomes depend significantly on three variables: pressure level, oxygen concentration, and session duration and frequency. Understanding these variables is essential for evaluating both clinical research and home-use products .

• Pressure Level (ATA): Medical-grade HBOT for neurological and systemic indications typically operates between 1.5 and 2.4 ATA. The higher the pressure, the more oxygen dissolves into plasma. Home-use mild hyperbaric chambers generally operate between 1.3 and 1.5 ATA due to safety and regulatory considerations.
• Oxygen Concentration: Clinical HBOT uses 100% pure oxygen delivered via mask or hood inside the chamber. Mild chambers may be pressurized with ambient air or supplemented oxygen — an important distinction that affects the degree of hyperoxia achieved.
• Session Length and Frequency: Standard clinical protocols run 60 to 90 minutes per session. Research protocols for Long COVID have typically used 40 sessions over 8 weeks, five days per week. Home users often adopt less intensive schedules, though the cumulative dose still matters.
• Total Number of Sessions: Most meaningful benefits in research appear after 20 to 40 sessions. Single or infrequent sessions are unlikely to produce the same neuroplastic and vascular changes observed in structured trials.

Targeting Brain Fog: HBOT's Neurological Mechanisms

Brain fog is one of the most commonly reported and most debilitating symptoms of both Long COVID and ME/CFS. Patients describe it as difficulty concentrating, slowed thinking, word-finding problems, and a persistent sense of mental cloudiness that is unrelated to sleep quality or effort level. Conventional medicine has few targeted treatments for it.

Hyperbaric oxygen therapy appears to act on brain fog through several complementary pathways. First, increased oxygen delivery to the brain directly supports the metabolic demands of neural tissue — neurons are among the most energy-hungry cells in the body and are exquisitely sensitive to oxygen availability. Second, HBOT has been shown to promote angiogenesis, the growth of new blood vessels, which can restore perfusion to chronically hypoperfused regions .

Third, and perhaps most intriguing, HBOT appears to trigger a process called neuroplasticity — the brain's capacity to reorganize and form new neural connections. Research has linked hyperbaric oxygen exposure to increased production of brain-derived neurotrophic factor (BDNF), a protein that supports the survival and growth of neurons. This may help explain why improvements in cognition continue even after a course of HBOT concludes.

Finally, HBOT has documented anti-inflammatory effects on the central nervous system. It appears to reduce the activity of pro-inflammatory cytokines and modulate microglial activation — the brain's resident immune cells that, when chronically activated, are believed to contribute directly to the neural dysfunction seen in both Long COVID and ME/CFS.

Practical Protocol Guidance for Long COVID and CFS

If you are considering hyperbaric oxygen therapy for Long COVID or chronic fatigue, building a thoughtful protocol is more important than simply getting access to a chamber. Here is a structured approach based on current evidence and clinical practice.

1. Consult a Physician First: HBOT is contraindicated in people with untreated pneumothorax, certain ear or sinus conditions, and those taking specific medications. A medical evaluation before starting is non-negotiable.
2. Define Your Starting Point: Document your baseline symptoms using a validated scale such as the Chalder Fatigue Scale or the Montreal Cognitive Assessment. This makes it possible to track progress objectively rather than relying solely on how you feel day-to-day.
3. Commit to a Minimum Course: Based on available research, aim for at least 20 to 40 sessions before evaluating results. Sporadic use is unlikely to produce the structural and vascular changes associated with meaningful improvement.
4. Start Low and Slow: If using a home chamber, begin with shorter sessions (30 to 45 minutes) and gradually increase duration. Some individuals experience temporary ear pressure discomfort or mild lightheadedness in early sessions.
5. Pair With Supporting Interventions: HBOT is most effective as part of a broader recovery approach. Gentle pacing, anti-inflammatory nutrition, sleep hygiene, and stress management all support the same biological systems that HBOT targets.
6. Track and Adjust: Keep a symptom journal and reassess your baseline measures every 10 sessions. Some people respond quickly; others require more sessions before noticing changes.

Safety Considerations and Who Should Be Cautious

Hyperbaric oxygen therapy has a strong safety record when used appropriately, but it is not without considerations. The most common side effects are ear and sinus barotrauma — discomfort caused by pressure changes — and temporary vision changes with prolonged high-pressure use. These are generally mild and reversible.

Oxygen toxicity is a concern at pressures above 2.0 ATA with 100% oxygen delivery, but this risk is essentially absent at the milder pressures used in home chambers. Seizures caused by central nervous system oxygen toxicity are rare and typically only occur in clinical settings at high pressures — they are not a meaningful risk in mild home-use contexts.

For people with Long COVID whose symptoms include significant cardiovascular involvement or autonomic dysfunction (such as POTS — postural orthostatic tachycardia syndrome), supervision by a knowledgeable clinician is particularly important. The pressure changes involved in HBOT can affect heart rate and blood pressure transiently, and monitoring during initial sessions is advisable in these populations.